Soleno Therapeutics (SLNO) EPS (Diluted) Growth (1y) (2015 - 2026)
Soleno Therapeutics (SLNO) EPS (Diluted) Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 8.02% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -4.52% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 96.09% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 144.25% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -99.90% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -11.18% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 315.14% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 96.41% |
| 10 | Soleno Therapeutics | 2.74 Bn | 2.49 Bn | 93.41 Mn | 162.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 162.38% |
| Dec 31, 2025 | 159.66% |
| Sep 30, 2025 | 62.19% |
| Jun 30, 2025 | -44.68% |
| Mar 31, 2025 | 65.70% |
| Dec 31, 2024 | -93.18% |
| Sep 30, 2024 | 18.42% |
| Jun 30, 2024 | -192.81% |
| Mar 31, 2024 | -208.05% |
| Dec 31, 2023 | 90.37% |
| Sep 30, 2023 | -534.81% |
| Jun 30, 2023 | 8.72% |
| Mar 31, 2023 | 23.10% |
| Dec 31, 2022 | -1,221.65% |
| Sep 30, 2022 | 48.87% |
| Jun 30, 2022 | 59.51% |
| Mar 31, 2022 | 32.40% |
| Dec 31, 2021 | 94.08% |
| Sep 30, 2021 | 6.13% |
| Jun 30, 2021 | 59.98% |